arrow
P

Pascal Richette

université catholique de lille
H指数:68
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring the potential of cluster analysis in identifying disease phenotypes in CPPD: Moving from intuition to insight

探索聚类分析在CPPD中识别疾病表型的潜力:从直觉到洞察

2026-09-240
OA
Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout

根据尿酸盐排泄分数评估痛风的男性对别嘌醇和非布司他的反应

2026-01-011
OAAI
Baseline Characteristics of the TRANSLATE2 Cohort: a Prospective Study on Rheumatoid Arthritis-associated Interstitial Lung Disease

TRANSLATE2队列的基线特征:一项关于类风湿关节炎相关间质性肺疾病的前瞻性研究

2025-10-170
OAAI
Exploring patients’ profiles associated with the resolution of acute calcium pyrophosphate arthritis treatedwith colchicine and prednisone: post hoc analysis of a randomized controlled trial

探索与秋水仙碱和泼尼松治疗急性焦磷酸钙关节炎后疾病缓解相关的患者特征:一项随机对照试验的回顾性分析

2025-09-020
OAAI
Spermidine reproduces the anti-inflammatory effects of intermittent fasting and prevents urate and calcium pyrophosphate crystal-induced inflammation

精胺再现了间歇性禁食的抗炎作用,并预防尿酸和焦磷酸钙晶体诱导的炎症。

2025-08-290
OAAI
Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort

早期外周型银屑病关节炎:法国全国性APACHE队列中前186例患者的基线特征

2025-05-270
OA
Addition of allopurinol to traditional Vietnamese medicine shows major improvement of 100 gout patients in a single center one-year prospective study

在单中心为期一年的前瞻性研究中,将别嘌呤醇添加到越南传统药物中显示出100例痛风患者的重大改善

2025-04-300
PRE
EUROVISCO Good Medical Practice Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Knee Osteoarthritis

欧洲骨关节炎研究学会(EUROVISCO)《关于使用透明质酸进行黏弹性补充疗法管理膝关节骨关节炎的良好医疗实践建议》

2025-03-290
PRE
Factors associated with dietary practices and beliefs on food of patients with rheumatic and musculoskeletal diseases: A multicentre cross-sectional study
2025-01-010
OAAI
Recommendations from the French Societies of Rheumatology andPhysical Medicine and Rehabilitation on the non-pharmacologicalmanagement of knee osteoarthritis
2024-10-012
OAAI